Frequency and timing of symptoms in infants screened for sepsis: Effectiveness of a sepsis-screening pathway

被引:3
作者
Madan, A
Adams, MM
Philip, AGS
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] El Camino Hosp, Mountain View, CA USA
关键词
D O I
10.1177/000992280304200102
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine the frequency and timing of symptoms and to evaluate the effectiveness of a sepsis-screcning pathway in term and near-term infants, data were collected prospectively for a period of I year from December 1, 2000, to November 30, 2001. Results confirmed that a sepsis-screening pathway using a combination of at least 2 serial complete blood cell count and C-reactive protein measurements in both symptomatic and asymptomatic infants is a safe, simple strategy that prevents unnecessary treatment of infants with risk factors with antibiotics. However, most infants with presumed or suspected early-onset sepsis are symptomatic. Routine treatment of asymptomatic infants with risk factors or prior treatment with intrapartum antibiotics is unnecessary. A combined approach of screening in the presence of risk factors and/or symptoms of sepsis and adequate follow-up for infants discharged at less than 72 hours of age may help reduce unnecessary treatment of infants with antibiotics.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 43 条
[1]   Antimicrobial prevention of early-onset group B streptococcal sepsis: Estimates of risk reduction based on a critical literature review [J].
Benitz, WE ;
Gould, JB ;
Druzin, ML .
PEDIATRICS, 1999, 103 (06)
[2]  
Benitz WE, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e77
[3]   Serial serum C-reactive protein levels in the diagnosis of neonatal infection [J].
Benitz, WE ;
Han, MY ;
Madan, A ;
Ramachandra, P .
PEDIATRICS, 1998, 102 (04) :E41
[4]   Vancomycin-resistant Enterococcus - Detection, epidemiology, and control measures [J].
Boyce, JM .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (02) :367-&
[5]   SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL EARLY-ONSET DISEASE .1. EPIDEMIOLOGIC RATIONALE [J].
BOYER, KM ;
GADZALA, CA ;
BURD, LI ;
FISHER, DE ;
PATON, JB ;
GOTOFF, SP .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) :795-801
[6]   The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants [J].
Bromberger, P ;
Lawrence, JM ;
Braun, D ;
Saunders, B ;
Contreras, R ;
Petitti, DB .
PEDIATRICS, 2000, 106 (02) :244-250
[7]  
Chiesa C, 2001, CLIN CHEM, V47, P1016
[8]   C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection [J].
Ehl, S ;
Gering, B ;
Bartmann, P ;
Hogel, J ;
Pohlandt, F .
PEDIATRICS, 1997, 99 (02) :216-221
[9]   EARLY DISCONTINUATION OF ANTIBIOTIC-TREATMENT IN NEWBORNS ADMITTED TO RULE OUT SEPSIS - A DECISION RULE [J].
ESCOBAR, GJ ;
ZUKIN, T ;
USATIN, MS ;
LEMESURIER, J ;
HONEYCHURCH, D ;
ARMSTRONG, MA ;
FOLCK, B .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (10) :860-866
[10]   Rehospitalization in the first two weeks after discharge from the neonatal intensive care unit [J].
Escobar, GJ ;
Joffe, S ;
Gardner, MN ;
Armstrong, MA ;
Folck, BF ;
Carpenter, DM .
PEDIATRICS, 1999, 104 (01) :e2